Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Rainey

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Analytical Biochemistry|May 15, 1993
Antimony quantification in Leishmania by electrothermal atomic absorption spectroscopyW L Roberts, P M Rainey
JAMA|November 16, 1994
Comparability of capillary and venous blood samples for lead screeningP M Rainey, D J Schonfeld
Antimicrobial Agents and Chemotherapy|September 1, 1993
Antileishmanial activity of sodium stibogluconate fractionsW L Roberts, P M Rainey
Clinical Chemistry|September 1, 1993
Interference in immunoassay measurements of total and free phenytoin in uremic patients: a reappraisalW L Roberts, P M Rainey
Annals of Emergency Medicine|September 28, 1999
Total iron binding capacity in iron overdoseW L Roberts, P M Rainey
Molecular and Biochemical Parasitology|April 1, 1991
A carbon-13 nuclear magnetic resonance analysis of the products of glucose metabolism in Leishmania pifanoi amastigotes and promastigotesP M Rainey, N E MacKenzie
Experimental Parasitology|August 1, 1993
Leishmania pifanoi: kinetics of messenger RNA expression during amastigote to promastigote transformation in vitroS M Campbell, P M Rainey
Antimicrobial Agents and Chemotherapy|June 1, 1995
In vitro antileishmanial properties of tri- and pentavalent antimonial preparationsW L Roberts, J D Berman, P M Rainey
Clinical Chemistry|October 1, 1996
Metabolite and matrix interference in phenytoin immunoassaysP M Rainey, K E Rogers, W L Roberts
Antimicrobial Agents and Chemotherapy|May 21, 1998
Characterization of the antimonial antileishmanial agent meglumine antimonate (glucantime)W L Roberts, W J McMurray, P M Rainey
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Analytical Biochemistry|May 15, 1993
Antimony quantification in Leishmania by electrothermal atomic absorption spectroscopyW L Roberts, P M Rainey
JAMA|November 16, 1994
Comparability of capillary and venous blood samples for lead screeningP M Rainey, D J Schonfeld
Antimicrobial Agents and Chemotherapy|September 1, 1993
Antileishmanial activity of sodium stibogluconate fractionsW L Roberts, P M Rainey
Clinical Chemistry|September 1, 1993
Interference in immunoassay measurements of total and free phenytoin in uremic patients: a reappraisalW L Roberts, P M Rainey
Annals of Emergency Medicine|September 28, 1999
Total iron binding capacity in iron overdoseW L Roberts, P M Rainey
Molecular and Biochemical Parasitology|April 1, 1991
A carbon-13 nuclear magnetic resonance analysis of the products of glucose metabolism in Leishmania pifanoi amastigotes and promastigotesP M Rainey, N E MacKenzie
Experimental Parasitology|August 1, 1993
Leishmania pifanoi: kinetics of messenger RNA expression during amastigote to promastigote transformation in vitroS M Campbell, P M Rainey
Antimicrobial Agents and Chemotherapy|June 1, 1995
In vitro antileishmanial properties of tri- and pentavalent antimonial preparationsW L Roberts, J D Berman, P M Rainey
Clinical Chemistry|October 1, 1996
Metabolite and matrix interference in phenytoin immunoassaysP M Rainey, K E Rogers, W L Roberts
Antimicrobial Agents and Chemotherapy|May 21, 1998
Characterization of the antimonial antileishmanial agent meglumine antimonate (glucantime)W L Roberts, W J McMurray, P M Rainey
Pageof 5